Benzinga · Feb 12, 2026
NASDAQ · OM
Outset Medical, Inc.
Healthcare · Medical - Devices
$4.03
Down-$0.16 (-3.82%)
Updated Nov 1, 2026, 8:49 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 77.96M
- P/E ratio
- -0.87
- Dividend yield
- 0.00%
- 52-week range
- $2.84 – $12.49
- Volume
- 81.5K
- Avg. volume
- 455.73K
Price performance · OM
OM price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
OM closed at $4.03 after 20 trading sessions, down 1.71% for the selected period.
- Last close
- $4.03
- Period change
- -1.71%
- Period low
- $3.80
- Period high
- $4.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $4.02 | $4.145 | $3.90 | $4.03 | 81.5K |
| Oct 29, 2026 | $4.34 | $4.445 | $4.15 | $4.19 | 77.79K |
| Oct 28, 2026 | $4.30 | $4.395 | $4.1563 | $4.34 | 37.54K |
| Oct 27, 2026 | $4.09 | $4.35 | $4.00 | $4.34 | 86.64K |
| Oct 26, 2026 | $4.13 | $4.145 | $4.00 | $4.08 | 68.05K |
| Oct 23, 2026 | $4.12 | $4.175 | $4.07 | $4.10 | 38.34K |
| Oct 22, 2026 | $3.99 | $4.27 | $3.92 | $4.17 | 69.71K |
| Oct 21, 2026 | $4.18 | $4.3468 | $3.98 | $4.05 | 78.78K |
| Oct 20, 2026 | $3.80 | $4.4394 | $3.80 | $4.22 | 381.99K |
| Oct 19, 2026 | $3.99 | $4.179 | $3.80 | $3.80 | 59.19K |
| Oct 16, 2026 | $4.09 | $4.2199 | $3.90 | $3.94 | 68.53K |
| Oct 15, 2026 | $3.85 | $4.105 | $3.80 | $4.08 | 54.72K |
| Oct 14, 2026 | $4.01 | $4.01 | $3.82 | $3.84 | 80.02K |
| Oct 13, 2026 | $3.99 | $4.14 | $3.965 | $4.06 | 68.53K |
| Oct 12, 2026 | $4.08 | $4.11 | $4.00 | $4.01 | 66.3K |
| Oct 9, 2026 | $4.15 | $4.27 | $4.02 | $4.05 | 73.22K |
| Oct 8, 2026 | $4.12 | $4.26 | $4.03 | $4.09 | 241.02K |
| Oct 7, 2026 | $4.06 | $4.25 | $4.06 | $4.21 | 134.99K |
| Oct 6, 2026 | $4.29 | $4.34 | $4.05 | $4.14 | 376.62K |
| Oct 5, 2026 | $3.96 | $4.155 | $3.85 | $4.10 | 203.09K |
Latest OM news
The latest Smart Investors Daily articles mentioning OM.
Stock researchCompany · Overview
Company
Market Activity
Research & News
OM research
Overview
Company profile and research snapshot.
Company profile
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $25.50
- Implied upside
- —
- Analysts
- 13
| Date | Firm | Rating | Target |
|---|---|---|---|
| Feb 12, 2026 | BTIG | Buy | — |
| Jan 7, 2026 | Stifel | Buy | — |
| Dec 16, 2025 | BTIG | Buy | — |
| Nov 11, 2025 | Stifel | Buy | — |
| Nov 11, 2025 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 12, 2026
BTIG Maintains Buy on Outset Medical, Lowers Price Target to $15
BTIG analyst Marie Thibault maintains Outset Medical (NASDAQ:OM) with a Buy and lowers the price target from $17 to $15.
ChartMill · Feb 11, 2026
Outset Medical Inc (NASDAQ:OM) Reports Q4 Revenue Beat but Wider Loss, Shares Fall
Outset Medical reports Q4 revenue beat but wider-than-expected loss, shares fall. Company highlights margin expansion and cost discipline for 2026.
SeekingAlpha · Feb 11, 2026
Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript
Outset Medical, Inc. (OM) Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsJames Mazzola - Vice President of Corporate Communications...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
